Literature DB >> 12685148

Successful treatment of severe orthostatic hypotension with erythropoietin.

Kazunobu Kawakami1, Haruhiko Abe, Nobuya Harayama, Yasuhide Nakashima.   

Abstract

A 71-year-old man, who was diagnosed with familial amyloidosis type I, was admitted for treatment of severe orthostatic hypotension associated with recurrent syncopal attacks. Head-up tilt testing demonstrated severe orthostatic hypotension (114/72 mmHg in the supine position and 62/34 mmHg in the upright position) with syncope or presyncope. Oral midodorine and fludrocortisone therapies failed to prevent his symptoms. After administration of subcutaneous erythropoietin, his blood pressure drop in the upright position was decreased and symptoms disappeared unassociated with improvement of anemia. Although previous reports have shown that the mechanism by which erythropoietin improves orthostatic hypotension is related to improvement in anemia, other mechanisms may also play a role.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12685148     DOI: 10.1046/j.1460-9592.2003.00158.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  5 in total

1.  Treatment of dysautonomia in extrapyramidal disorders.

Authors:  Tjalf Ziemssen; Heinz Reichmann
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

2.  Current Management of Syncope: Treatment Alternatives.

Authors:  Carlos A. Morillo; Adrián Baranchuk
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-10

3.  Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice.

Authors:  Robert E Schmidt; Karen G Green; Dongyan Feng; Denise A Dorsey; Curtis A Parvin; Jin-Moo Lee; Qinlgi Xiao; Michael Brines
Journal:  Exp Neurol       Date:  2007-10-29       Impact factor: 5.330

4.  Impaired orthostatic blood pressure stabilization and reduced hemoglobin in chronic kidney disease.

Authors:  Wenjin Liu; Lulu Wang; Xiaoqin Huang; Weichun He; Zongwei Song; Junwei Yang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-08-30       Impact factor: 3.738

Review 5.  Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms.

Authors:  Sabine Eschlböck; Gregor Wenning; Alessandra Fanciulli
Journal:  J Neural Transm (Vienna)       Date:  2017-10-22       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.